Tocilizumab for severe COVID-19 pneumonia
- PMID: 32838327
- PMCID: PMC7431163
- DOI: 10.1016/S2665-9913(20)30284-8
Tocilizumab for severe COVID-19 pneumonia
References
-
- National Institute of Diabetes and Digestive and Kidney Diseases LiverTox: clinical and research information on drug-induced liver injury. 2012. https://www.ncbi.nlm.nih.gov/books/NBK548243/ - PubMed
-
- Genovese MC, Kremer JM, van Vollenhoven RF. Transaminase levels and hepatic events during tocilizumab treatment: pooled analysis of long-term clinical trial safety data in rheumatoid arthritis. Arthritis Rheumatol. 2017;69:1751–1761. - PubMed
LinkOut - more resources
Full Text Sources